Industry / Estonia
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Spending On Reimbursed Drugs Continues To Rise
September 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Estonia's Health Insurance Fund (EHIF) registered a 15.9% increase in spending on reimbursed medicines during 2007, according the fund's Annual Report 2007. A total of EEK1.12bn (US$102mn) was spent across the five reimbursement groups, representing 11.0% of total healthcare expenditure by the group.